Randomized trial · people

Tesamorelin had little effect on simvastatin and ritonavir levels

Checked against the paper Randomized trialPublished by PepVault

The takeaway

In healthy volunteers, tesamorelin barely changed blood levels of simvastatin and ritonavir.

Kind
Randomized trial
Studied in
People
Published
2013
Journal
Clin Pharmacol Drug Dev

What they tested

The team tested whether tesamorelin changes CYP3A activity by checking its effect on blood levels of simvastatin and ritonavir.

How the study was done

Two randomized, two-way crossover studies in healthy volunteers, where each person had both treatments in turn. In one treatment, people took 2 mg tesamorelin on Days 1-7 plus a single 80 mg simvastatin or 100 mg ritonavir dose on Day 6; in the other, they took the simvastatin or ritonavir dose alone on Day 6.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking tesamorelin? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

For simvastatin, the ratios of total exposure (AUC, the drug's total amount in the blood over time) and peak level (Cmax) with versus without tesamorelin, along with their 90% confidence intervals, all stayed inside the standard 80-125% no-effect range. For ritonavir, total exposure also stayed inside that range, but the lower bound for peak level was 74.8%, pointing to a lower peak. The ritonavir ratios were about 90%, which the team judged a minor drop. They concluded that tesamorelin's effect on CYP3A activity was minimal, if any.

What it doesn’t show

These were short studies in healthy volunteers, with a single dose of each partner drug given on Day 6 of a 7-day tesamorelin course. They don't show what happens in patients, with long-term use, or with other medicines.

The paper

Teng et al. Impact of Tesamorelin, a Growth Hormone-Releasing Factor (GRF) Analogue, on the Pharmacokinetics of Simvastatin and Ritonavir in Healthy Volunteers. Clin Pharmacol Drug Dev. 2013.

The compound

More studies on Tesamorelin

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking tesamorelin? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo